Menu

Image of the Day: Bird-of-Paradise

A unique courtship dance clued researchers in to the fact that they had a new species on their hands.

Apr 25, 2018
The Scientist Staff, The Scientist Staff

Cape presentation display of L. superba (A, C, E) and L. niedda (B, D, F)EDWIN SCHOLES, TIM LAMAN

Birds-of-paradise (Aves: Paradisaeidae), a family of passerine birds that includes more than 40 species, have an elaborate courtship display. The male dances frenetically, showing off brightly colored plumage and calling to his mate. Now, researchers have identified a new species in the bird-of-paradise genus Lophorina by analyzing the first-ever audiovisual recordings of its courtship dance. They describe their findings in a study published last week (April 16) in PeerJ

The new species, L. niedda, is the fourth bird-of-paradise species found in the Bird’s Head region of Indonesian New Guinea. Its courtship routine begins with more-intense shaking of its cape—a set of ornamental feathers on its head and upper back—than its close cousin L. superba exhibits. It also includes a more-pronounced cape presentation later in the dance.

E. Scholes, T. Laman, “Distinctive courtship phenotype of the Vogelkop Superb Bird-of-Paradise Lophorina niedda Mayr, 1930 confirms new species status,” PeerJ, doi:10.7717/peerj.4621, 2018.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!